Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
UPL Corporation Limited maintains a focused presence in the Biotechnology & Pharmaceuticals sector. The portfolio currently includes 1 pending office action located in 1 distinct art unit. This concentration indicates a specific area of technical interest for the company's current filings.
ARMSTRONG, SUSANNAH SIPPLE is the 1 distinct examiner for this portfolio and holds the 1 busiest examiner pending action. Since all prosecution activity is directed through a single examiner, the entity experiences a centralized review process. This structure allows for a very direct line of communication with the patent office.
Practitioners should note that the lack of examiner variety necessitates a highly targeted response strategy. Because there are no other active cases, the specific feedback from this examiner is the only guidance available for the current portfolio. Success in this environment depends on a clear and persuasive communication with the assigned art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16942422 | Compositions to Control the Release Rates of Chemical Pesticides | ARMSTRONG, SUSANNAH SIPPLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16942422 | Compositions to Control the Release Rates of Chemical Pesticides | ARMSTRONG, SUSANNAH SIPPLE | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16942422 | Compositions to Control the Release Rates of Chemical Pesticides | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §102§103§112 | Non-Final OA | — | Pending | Jul 29, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUPL Corporation Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Susannah Sipple Armstrong has the most, with 1 of UPL Corporation Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
